BIOGEN SPAIN, S.L. secures contract for Immunosuppressive Agents-Acquisition and centralized supply of drugs for human use of medicines that contains the following active ingredients: Fampridine, Peginterferon Beta-1A, Natalizumab, Dirroximel Fumarate to the centers of the Valencian Public Health.

Spain, Aug. 27 -- Spain based BIOGEN SPAIN, S.L. has secured contract from Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad for Immunosuppressive Agents-Acquisition and centralized supply of drugs for human use of medicines that contains the following active ingredients: Fampridine, Peginterferon Beta-1A, Natalizumab, Dirroximel Fumarate to the centers of the Valencian Public Health.. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....